Balyasny Asset Management
ANGO icon

Balyasny Asset Management’s AngioDynamics ANGO Stock Holding History

Balyasny Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Buy
+12,125
New +$138K ﹤0.01% 2851
2025
Q4 		– Sell
-172,780
Closed -$1.93M – 3052
2025
Q3 		$1.93M Buy
172,780
+133,609
+341% +$1.29M ﹤0.01% 1814
2025
Q2 		$389K Sell
39,171
-60,247
-61% -$590K ﹤0.01% 2391
2025
Q1 		$934K Sell
99,418
-11,433
-10% -$120K ﹤0.01% 2021
2024
Q4 		$1.02M Buy
110,851
+48,522
+78% +$357K ﹤0.01% 1941
2024
Q3 		$485K Buy
62,329
+42,784
+219% +$309K ﹤0.01% 2271
2024
Q2 		$118K Sell
19,545
-5,542
-22% -$34.2K ﹤0.01% 2393
2024
Q1 		$147K Buy
+25,087
New +$149K ﹤0.01% 2461
2023
Q4 		– Sell
-116,596
Closed -$852K – 2470
2023
Q3 		$852K Buy
116,596
+85,517
+275% +$712K ﹤0.01% 1604
2023
Q2 		$324K Sell
31,079
-116,686
-79% -$1.12M ﹤0.01% 1969
2023
Q1 		$1.53M Sell
147,765
-890,648
-86% -$11.4M ﹤0.01% 1561
2022
Q4 		$14.3M Buy
1,038,413
+829,408
+397% +$11.5M 0.04% 603
2022
Q3 		$4.28M Sell
209,005
-246,025
-54% -$5.4M 0.01% 1080
2022
Q2 		$8.8M Buy
455,030
+194,099
+74% +$3.98M 0.03% 701
2022
Q1 		$5.62M Buy
+260,931
New +$5.92M 0.02% 906
2021
Q4 		– Sell
-146,094
Closed -$3.79M – 2206
2021
Q3 		$3.79M Buy
146,094
+71,395
+96% +$1.91M 0.02% 920
2021
Q2 		$2.03M Buy
+74,699
New +$1.82M 0.01% 1004
2016
Q2 		– Sell
-15,000
Closed -$184K – 1148
2016
Q1 		$184K Buy
+15,000
New +$166K ﹤0.01% 1140

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Balyasny Asset Management's ANGO Position: Q2 2026 in Review

Balyasny Asset Management opened a new position in AngioDynamics (ANGO) in Q2 2026: 12,125 shares worth $158K. The stake represents ﹤0.01% of the portfolio and ranks #2851 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in ANGO as recently as Q3 2025.

Balyasny Asset Management first reported a position in ANGO in Q1 2016 and has held it in 18 quarters since. The position peaked at $14.3M in Q4 2022. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Balyasny Asset Management held 12,125 shares of AngioDynamics worth $158K as of Q2 2026.
  • AngioDynamics was a new Balyasny Asset Management position in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2851 holding.
  • Balyasny Asset Management first reported a position in AngioDynamics in Q1 2016 and has held it in 18 quarters since.
  • Balyasny Asset Management's AngioDynamics position peaked at $14.3M in Q4 2022.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.